Cloning and characterization of a 77-kDa oestrogen receptor isolated from a human breast cancer cell line

British Journal of Cancer

Volumn 75, Issue 1, 1997, Pages 17-27

  Pink, J J ^a   Fritsch, M ^a,c   Bilimoria, M M ^b   Assikis, V J ^b   Jordan, V C ^a,b  

^a UNIVERSITY OF WISCONSIN   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Breast cancer; Exon duplication; MCF 7; Oestrogen receptor

Indexed keywords

DNA; ESTRADIOL; ESTROGEN RECEPTOR; LUCIFERASE; MESSENGER RNA; MUTANT PROTEIN; TAMOXIFEN AZIRIDINE; TRITIUM;

ARTICLE; BREAST CANCER; CELL STRAIN MCF 7; CONTROLLED STUDY; DNA TRANSFECTION; EXON; GENE DUPLICATION; GENE ISOLATION; HORMONE RECEPTOR INTERACTION; HORMONE RESPONSIVE ELEMENT; HUMAN; HUMAN CELL; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN EXPRESSION; RADIOASSAY; RECEPTOR GENE; REPORTER GENE; TRANSCRIPTION REGULATION;

EID: 0031012317     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.4     Document Type: Article

References (33)

1. + RNA. Biotechniques 6: 114-116
2. Berthois Y, Katzenellenbogen JA and Katzenellenbogen BS (1986) Phenol red in tissue culture media is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture. Proc Natl Acad Sci USA 83: 2496-2500
3. Brooks SC, Locke ER and Soule HD (1973) Estrogen receptor in a human cell line (MCF-7) from breast carcinoma. J Biol Chem 248: 6251-6253
4. Caileau R, Young R, Olive M and Reeves WJJ (1974) Breast tumor cell lines from pleural effusions. J Natl Cancer Inst 53: 661-674
5. Catherino WH and Jordan VC (1995) Increasing the number of tandem estrogen response element increases the estrogenic activity of a tamoxifen analogue. Cancer Lett 92: 39-47
6. Cho H and Katzenellenbogen BS (1993) Synergistic activation of estrogen receptor-mediated transcription by estradiol and protein kinase activators. Mol Endocrinol 7: 441-452
7. Fritsch M, Anderson I and Gorski J (1993) Structural characterization of the trypsinized estrogen receptor. Biochemistry 32: 14000-14008
8. Fritsch M, Leary CM, Furlow JD, Ahrens H, Schuh TJ, Mueller GC and Gorski J (1992) A ligand-induced conformational change in the estrogen receptor is localized in the steroid binding domain. Biochemistry 31: 5303-5311
9. Green S and Chambon P (1991) The oestrogen receptor: from perception to mechanism. In Nuclear Hormone Receptors: Molecular Mechanisms, Cellular Functions. Clinical Abnormalities. Parker MG (ed.) pp. 15-37. Academic Press: London.
10. Green S, Issemann I and Sheer E (1988) A versatile in vivo and in vitro eukaryotic expression vector for protein engineering. Nucleic Acids Res 16: 369
11. Greene GL, Fitch FW and Jensen EV (1980) Monoclonal antibodies to estrophilin: probes for the study of estrogen receptors. Proc Natl Acad Sci USA 77: 157-161
12. Ince BA, Zhuang Y, Wrenn CK, Shupiro DJ and Katzenellenbogen BS (1993) Powerful dominant negative mutants of the human estrogen receptor. J Biol Chem 268: 14026-14032
13. Jiang SY, Wolf DM, Yingling JM, Chang C and Jordan VC (1992a) An estrogen receptor positive MCF-7 clone that is resistant to antiestrogens and estradiol. Mol Cell Endocrinol 90: 77-86
14. Jiang SY, Langan FS, Stella AL, McCague R and Jordan VC (1992b) Point mutation of estrogen receptor (ER) in the ligand-binding domain changes the pharmacology of antiestrogens in ER-negative breast cancer cells stably expressing complementary DNAs for ER. Mol Endocrinol 6: 2167-2174
15. Katzenellenbogen BS, Kendra KL, Norman MJ and Berthois Y (1987) Proliferation. hormonal responsiveness, and estrogen receptor content of MCF-7 human breast cancer cells grown in the short-term and long-term absence ot estrogens. Cancer Res 47: 4355-4360
16. Keydar I, Chen L, Karby S, Weiss FR, Delarea J, Radu M, Chaitcik S and Brenner HJ (1979) Establishment and characterization of a cell line of human breast cancer origin. Eur J Cancer 15: 659-670
17. Kumar V and Chambon P (1988) The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer. Cell 55: 145-156
18. Luyten GP, Hoogeveen AT and Galjaard H (1985) A fluorescence staining method for the demonstration and measurement of lysosomal enzyme activities in single cells. J Histochem Cytochem 33: 965-968
19. MacGregor GR and Caskey CT (1989) Construction of plasmids that express E. coli beta-galactosidase in mammalian cells. Nucleic Acids Res 17: 2365
20. Murphy CS, Meisner LF, Wu SQ and Jordan VC (1989) Short-and long-term estrogen deprivation of T47D human breast cancer cells in culture. Eur J Cancer Clin Oncol 25: 1777-1788
21. Murphy CS, Pink JJ and Jordan VC (1990) Characterization of a receptor-negative, hormone-nonresponsive clone derived from a T47D human breast cancer cell line kept under estrogen-free conditions. Cancer Res 50: 7285-7292
22. Paik S, Hartmann DP, Dickson RB and Lippman ME (1994) Antiestrogen resistance in ER positive breast cancer cells. Breast Cancer Res Treat 31: 301-307
23. Paridaens, R (1995) Hormonal resistance in breast cancer. In Drug and Hormonal Resistance in Breast Cancer: Cellular and Molecular Mechanisms. Dickson RB and Lippman ME (eds) pp. 21-37. Ellis Horwood: Hemel Hempstead, UK.
24. Pink JJ, Jiang SY, Fritsch M and Jordan VC (1995) An estrogen independent MCF-7 breast cancer cell line which contains a novel 80 kilodalton estrogen receptor related protein. Cancer Res 55: 2583-2590
25. Pink JJ and Jordan VC (1996) Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines. Cancer Res 56: 2321-2330
26. Pink JJ, Wu SQ, Wolf DM, Bilimoria MM and Jordan VC (1996a) A novel 80 kilodalton estrogen receptor containing a duplication of exons 6 and 7. Nucleic Acids Res 24: 962-969
27. Pink JJ, Billimoria MM, Assikis VJ and Jordan VC (1996b) Irreversible loss of the estrogen receptor in T47D breast cancer cells following prolonged estrogen deprivation. Br J Cancer 74: 1227-1236
28. Ponglikitmongkol M, Green S and Chambon P (1988) Genomic organization of the human oestrogen receptor gene. EMBO J 7: 3385-3388
29. Sluyser M (1995) Mutations in the estrogen receptor gene. Hum Mutat 6: 97-103
30. Soule HD, Vasquez J, Long A, Albert S and Brennan M (1973) A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst 51: 1409-1416
31. Tora L, Mullick A, Metzger D, Ponglikitmongkol M, Park I and Chambon P (1989) The cloned human oestrogen receptor contains a mutation which alters its hormone binding properties. EMBO J 8: 1981-1986
32. Wei LL, Mangel WF and Katzenellenbogen BS (1985) Biological activities of tamoxifen aziridine, an antiestrogen-based affinity label for the estrogen receptor, in vivo and in vitro. J Steroid Biochem 23: 875-881
33. Welshons WV and Jordan VC (1987) Adaptation of estrogen-dependent MCF-7 cells to low estrogen (phenol red-free) culture. Eur J Cancer Clin Oncol 23: 1935-1939